Literature DB >> 383749

Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius.

M P Arala-Chaves, T B Higerd, M T Porto, J Munoz, J M Goust, H H Fudenberg, C B Loadholt.   

Abstract

Products secreted by Streptococcus intermedius were studied for their effects on the immune response. Three different preparations of crude extracellular products from S. intermedius (CEP-Si) were found to have powerful suppressor activity in vitro as shown by inhibition of human lymphocyte proliferation (uptake of [3H]thymidine) and protein synthesis in response to a wide variety of stimulants, including mitogens and antigens, and suppression of plaque formation by human cells in response to sheep erythrocytes. CEP-Si was noncytotoxic, because cells incubated with high concentrations of CEP-Si and subsequently washed were viable and recovered their ability to respond to mitogens, and because leukocyte migration was not inhibited by CEP-Si, nor was the release of leukocyte migration inhibitory factor from sensitized lymphocytes. The possibility of antigen or mitogen competition was excluded. The effects of CEP-Si in vitro were time dependent and did not require the presence of monocytes. Cells pretreated with CEP-Si and then washed suppressed plaque formation by fresh autologous cells in highly stimulated cultures. CEP-Si injected into C57BL/6 mice also strongly suppressed their immune response to sheep erythrocytes, and the in vivo suppression was correlated with the effects of CEP-Si in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 383749      PMCID: PMC372195          DOI: 10.1172/JCI109553

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

Review 1.  The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.

Authors:  J E Clausen
Journal:  Dan Med Bull       Date:  1975-07

2.  Activation of human B lymphocytes. V. Kinetics and mechanisms of suppression of plaque-forming cell responses by concanavalin A-generated suppressor cells.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1978-03       Impact factor: 5.422

3.  Inhibition of rat mixed lymphocyte cultures by suppressor macrophages.

Authors:  J R Oehler; R B Herberman; D A Campbell; J Y Djeu
Journal:  Cell Immunol       Date:  1977-03-15       Impact factor: 4.868

4.  Inhibition of 125IUdR incorporation by supernatants from macrophage and lymphocyte cultures: a cautionary note.

Authors:  R Evans; C G Booth
Journal:  Cell Immunol       Date:  1976-09       Impact factor: 4.868

5.  T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.

Authors:  K Bro-Jorgensen; F Güttler; P N Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

6.  Role of adherent cells in immune responses to phytohemagglutinin and concanavalin A.

Authors:  M P Arala-Chaves; L Hope; J H Korn; H Fudenberg
Journal:  Eur J Immunol       Date:  1978-02       Impact factor: 5.532

7.  Potentiation of the T lymphocyte response to mitogens IV. Serum-free production and testing of macrophage soluble products.

Authors:  D C Hoessli; A P Jones; B H Waksman
Journal:  Cell Immunol       Date:  1977-05       Impact factor: 4.868

8.  Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1977-06       Impact factor: 5.422

9.  Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A.

Authors:  D G Colley; F A Lewis; R W Goodgame
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

10.  The evolution of immunosuppressive cell populations in experimental mycobacterial infection.

Authors:  W E Bullock; E M Carlson; R K Gershon
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

View more
  11 in total

1.  Identification of NAD+ synthetase from Streptococcus sobrinus as a B-cell-stimulatory protein.

Authors:  Isabel Veiga-Malta; Margarida Duarte; Márcia Dinis; Pedro Madureira; Paula Ferreira; Arnaldo Videira
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

Review 2.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

3.  Protective effect of a T-cell-dependent immunosuppressive, B-cell-mitogenic protein (F3'EP-Si, or P90) produced by Streptococcus intermedius.

Authors:  M Lima; A Bandeira; D Portnoi; A Ribeiro; M A Chaves
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

4.  Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.

Authors:  H Nagamune; C Ohnishi; A Katsuura; K Fushitani; R A Whiley; A Tsuji; Y Matsuda
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 5.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

6.  Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.

Authors:  Hong-Zhou Lu; Xin-Hua Weng; Bai Zhu; Haijing Li; You-Kuan Yin; Yong-Xin Zhang; David W Haas; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Immune suppressive effects of Helicobacter pylori on human peripheral blood mononuclear cells.

Authors:  U Knipp; S Birkholz; W Kaup; W Opferkuch
Journal:  Med Microbiol Immunol       Date:  1993-05       Impact factor: 3.402

8.  Strong mitogenic effect for murine B lymphocytes of an immunosuppressor substance released by Streptococcus intermedius.

Authors:  M P Arala-Chaves; A S Ribeiro; M M Santarém; A Coutinho
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Clinical appearance of orofacial infections of odontogenic origin in relation to microbiological findings.

Authors:  A Heimdahl; L von Konow; T Satoh; C E Nord
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

Review 10.  The role of Streptococcus intermedius in brain abscess.

Authors:  A K Mishra; P-E Fournier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-28       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.